Among these, the miR-223/PTEN/PI3K/AKT axis has been identified as a major driver of chemoresistance in ovarian cancer cells, underscoring exosomes as potential therapeutic targets to restore chemosensitivity. This evidence concerns the gene AKT1 and ovarian cancer.